We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.

AusPAR: Influenza Haemagglutinin Recombinant

Australian Public Assessment Report

AusPAR

AusPAR: Influenza Haemagglutinin Recombinant [PDF, 654.92 KB]

AusPAR: Influenza Haemagglutinin Recombinant [Word, 1.56 MB]

Attachment 1: Product Information for Influenza Haemagglutinin Recombinant [PDF, 234.11 KB]

Attachment 1: Product Information for Influenza Haemagglutinin Recombinant [Word, 73.11 KB]

Device/Product Name

Flublok Quadrivalent

Active ingredients

Influenza Haemagglutinin Recombinant

AusPAR Date

8 July 2021

Published

23 August 2021

Submission Number

PM-2019-04824-1-2

Submission Type

New biological entity

Decision

Approved